text

U.S. drugmaker Eli Lilly pauses antibody trial over safety concerns

The Lilly France company unit. /CFPU.S. drugmaker Eli Lilly said Tuesday it has paused its trial of a combination antibody treatment for COVID-19 for safety reasons.The